Clinical trials: Breast Cancer (Early Breast Cancer)
Early Breast Cancer
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
The best available evidence suggests that pregnancy after breast cancer does not increase a woman's risk of developing a recurrence from her breast cancer.
- Trial name
- POSITIVE (NCT02308085)
- Testing
- Endocrine therapy interruption
- Where
- 211 sites in United States, Australia and 20 more
- Volunteers
- 518 people
- Sponsor
- ETOP IBCSG Partners Foundation
Cancer of Breast
Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: WBI Versus APBI
Selected patients with early stage breast cancer undergone conservative surgery were randomized in two arms: Hypofractionated Whole Breast Irradiation versus Accelerated Partial Breast Irradiation.
- Trial name
- NCT02375048
- Testing
- Hypofractionated WBI, Accelerated Partial Breast Irradiation
- Where
- Italy
- Volunteers
- 179 people
- Sponsor
- Istituto Clinico Humanitas
Breast Cancer
IMproving PAtient UndeRstanding of GEP TEst Results: Phase 4
The primary aim of the study is to determine if provision of a patient information film about Oncotype DX improves patients' knowledge and understanding about Gene Expression Profiling (GEP) test and risk of recurrence results in…
- Trial name
- IMPARTER (NCT06703567)
- Testing
- Standard Policy, Standard Policy + GEP Information Film
- Where
- Italy
- Volunteers
- 82 people
- Sponsor
- European Institute of Oncology
Breast Cancer
Circulating Tumor DNA Guided Boost Therapy in Early Triple Negative Breast Patients With Residual Disease After Neoadjuvant Therapy
Early triple negative breast cancer patients who do not achieve pathologic complete response after neoadjuvant chemotherapy with or without immunotherapy have bad prognosis.
- Trial name
- NCT06992336
- Testing
- Apatinib, Camrelizumab, Capecitabine
- Where
- China
- Volunteers
- 430 people
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Early-stage Breast Cancer
Impact of Exercise on Quality of Life of EBC Patients on Treatment With Adjuvant AI With or Without CDK4/6 Inhibitors
This is a national clinical trial (Spain), conducted in approximately 5 sites, where patients who agree to participate will be included in one of two exercise program groups: the experimental group (a combined resistance and…
- Trial name
- EX-AI (NCT07215364)
- Testing
- Training program
- Where
- 5 sites in Spain
- Volunteers
- 74 people
- Sponsor
- Spanish Breast Cancer Research Group
Ductal Carcinoma In-situ
Diagnostic Study of Early Breast Cancer Using Ultrasound
This is a pilot study designed to investigate new techniques to guide the appropriate diagnosis and treatment of Ductal Carcinoma In-situ (DCIS).
- Trial name
- NCT01391039
- Testing
- Perflutren lipid microsphere
- Where
- Canada
- Volunteers
- 12 people
- Sponsor
- Sunnybrook Health Sciences Centre
Breast Cancer
An Early Phase Clinical Trial to Evaluate the Feasibility of CEST MRI in Patients With Early Stage Breast Cancer
Evaluate the feasibility of translating preclinical Chemical Exchange Saturation Transfer (CEST) MRI protocol designed to estimate tumor extracellular pH (pHe) to a clinical MRI scanner in women with early stage breast cancer.
- Trial name
- NCT02380209
- Testing
- CEST MRI
- Where
- United States
- Volunteers
- 8 people
- Sponsor
- University of Arizona
Early Stage Breast Cancer, Neoplasm of the Breast
Targeted Intraoperative Therapy Registry at Bethesda North Hospital (TARGIT)
The purpose of this study is to create a registry to evaluate the use of intra-operative radiation therapy (IORT) and to study the efficacy and toxicity of breast radiotherapy given intra-operatively as a single fraction after…
- Conditions
- Early Stage Breast Cancer, Neoplasm of the Breast, Breast Tumor
- Trial name
- TARGIT (NCT02364960)
- Where
- United States
- Volunteers
- 16 people
- Sponsor
- TriHealth Inc.
Breast Cancer
Radiation Therapy Followed by Surgery in Treating Patients With Early-Stage Breast Cancer
RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Giving CT-guided accelerated radiation therapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed.
- Trial name
- PAPBI (NCT01024582)
- Testing
- biopsy, fine-needle aspiration, accelerated partial breast irradiation
- Where
- Netherlands
- Volunteers
- 139 people
- Sponsor
- The Netherlands Cancer Institute
Breast Cancer
Improving Decision Role Concordance in Newly Diagnosed Breast Cancer Patients
The goal of this project is to test the effects of the Patient Preference Scale as the basis for a clinical intervention for role negotiation in breast cancer surgery decisions and the Patient Perception Scale to measure role…
- Trial name
- NCT03350854
- Testing
- Patient Preference in Treatment Decision Making
- Volunteers
- 100 people
- Sponsor
- University of Utah
Breast Cancer
A Real-World Study of Early Breast Cancer Patients Eligible for Treatment With CDK4/6 Inhibitors
The aim of this study was to describe treatment patterns, patient characteristics and clinical outcomes among hormone receptor positive/human epidermal growth factor receptor 2 negative (HR+/HER2-) early breast cancer (eBC)…
- Trial name
- LEEWARD (NCT07647042)
- Where
- United States
- Volunteers
- 750 people
- Sponsor
- Novartis Pharmaceuticals
Breast Cancer
Genotype and Phenotype in Early Onset Breast Cancer in Young Women on the Two Shores of the Mediterranean Sea
Breast cancer are common on mediterranean basin. Epidemiological data suggest that breast cancer in young women (< 40years old) is more aggressive in the Maghreb countries comparatively to western countries.
- Trial name
- MediSein (NCT02541188)
- Testing
- Genetic analysis
- Where
- France
- Volunteers
- 460 people
- Sponsor
- University Hospital, Montpellier
Breast Cancer, TNBC - Triple-Negative Breast Cancer
To Evaluate the Efficacy of Toripalimab Combined With Chemotherapy After HIFU Induction in the Treatment of Early Triple-negative Breast Cancer
To investigate the efficacy and safety of terbinumab combined with chemotherapy (epirubicin + cyclophosphamide → nab-paclitaxel + carboplatin) in neoadjuvant therapy of triple-negative breast cancer after HIFU.
- Trial name
- HIFU (NCT05491694)
- Testing
- Toripalimab, Epirubicin, High Intensity Focused Ultrasoun
- Volunteers
- 20 people
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
Radiation Toxicity
3DCRT vs. IMRT in Early Breast Cancer
It has been not clinically determined whether TomoDirect was dosimetrically better than 3D-CRT for Asian patients with early breast cancer.
- Trial name
- NCT02440191
- Testing
- 3DCRT
- Where
- South Korea
- Volunteers
- 690 people, healthy volunteers welcome
- Sponsor
- Jong Hoon Lee
Breast Cancer
RAD 1802: Pilot Trial of Five Fraction Stereotactic Body Radiotherapy for Early Stage Breast Cancer Patients Eligible for Post-Operative Accelerated Partial Breast Irradiation (APBI)
This study offers 5 fractions of radiation treatment through partial breast irradiation in patients with early stage breast cancer after having a lumpectomy.
- Trial name
- NCT03643861
- Testing
- 5 Fraction Stereotactic Body Radiation Therapy
- Where
- 2 sites in United States
- Volunteers
- 40 people
- Sponsor
- University of Alabama at Birmingham
Breast Cancer
Tamoxifen in Treating Women With Breast Cancer
RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using tamoxifen may fight breast cancer by blocking the uptake of estrogen by the tumor cells.
- Trial name
- NCT00003678
- Testing
- tamoxifen citrate, adjuvant therapy
- Where
- United Kingdom
- Volunteers
- 20,000 people
- Sponsor
- University Hospital Birmingham
Early Breast Cancer, Skin Condition
An Observational Real-world Study to Evaluate the Impact of Dermatological Toxicities on the Quality of Life in Patients With Early Breast Cancer Treated With Adjuvant Endocrine Therapy - BCARE (Breast Cancer Adjuvant Real-world Evaluation of Dermatological Adverse Events)
The goal of this European observational study (Frane, Spain, italy, Spain and Greece) is to describe the quality of life related to dermatological toxicities, in adult women patients with Early Breast Cancer (EBC), treated with…
- Conditions
- Early Breast Cancer, Skin Condition, Quality of Life
- Trial name
- BCARE (NCT06690489)
- Where
- 9 sites in France, Greece and 2 more
- Volunteers
- 155 people
- Sponsor
- Pierre Fabre Medicament
Breast Cancer, Early-Onset
CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage
Primary Objective: 1) To examine the impact of Circulating tumor DNA (ctDNA) (expressed as mean tumor molecules per ml) on treatment decision making in patients with early stage breast cancer after neoadjuvant therapy and surgery…
- Trial name
- NCT05333874
- Testing
- Neoadjuvant chemotherapy administered before surgical extraction of a tumor, Observational
- Where
- 12 sites in United States
- Volunteers
- 34 people
- Sponsor
- Rutgers, The State University of New Jersey
Breast Cancer
Dietary Habits, Nutritional Knowledge and Physical Activity Assessment in Early Stage Breast Cancer Patients
The advances in early detection coupled with improvements in treatments have led to an ever increasing number of breast cancer survivors.
- Trial name
- DEMETRA (NCT06073418)
- Where
- Italy
- Volunteers
- 1,098 people
- Sponsor
- Centro di Riferimento Oncologico - Aviano
Breast Cancer
Carboplatin in EARLY Triple Negative Breast Cancer Trial (PEARLY Trial)
This is a randomized, open-label, multicenter, phase III study comparing anthracyclines followed by taxane to anthracyclines followed by taxane plus carboplatin as (neo)adjuvant therapy in patients with triple-negative breast…
- Trial name
- NCT02441933
- Testing
- taxane plus carboplatin, Taxane
- Where
- 21 sites in South Korea
- Volunteers
- 878 people
- Sponsor
- Yonsei University
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.